8-K: HCW Biologics Holds Annual Meeting Amid Technical Difficulties, Announces Board Resignation

HCW Biologics Inc. successfully held its 2025 Annual Meeting of Stockholders despite technical difficulties, electing directors and ratifying auditors, while also accepting a board member's resignation.

Summary

• HCW Biologics Inc. held its 2025 Annual Meeting of Stockholders on June 17, 2025.
• The company's service provider, Broadridge Financial Solutions, Inc., experienced technical difficulties during the virtual meeting, potentially preventing some stockholders from logging in.
• Despite the technical issues, a quorum was reached through in-person or proxy attendance, validating the meeting.
• Stockholders elected Scott T. Garrett as a Class I director for a three-year term expiring at the 2028 Annual Meeting, with 534,541 votes For and 9,185 Withheld.
• Gary M. Winer, a nominee for Class I director, received 133,365 votes For and 410,361 Withheld, indicating he was not re-elected.
• After the Annual Meeting, Gary M. Winer resigned from the Company's Board of Directors, effective immediately; his resignation was not due to any disagreement with the Company.
• The Board of Directors is not required to fill the vacant seat and has determined not to appoint a replacement director currently.
• Stockholders ratified the appointment of Crowe LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with 693,874 votes For.
• A replay of the Annual Meeting is available for one year, and stockholders can submit questions via email until July 31, 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the technical difficulties impacting shareholder participation and the non-re-election and subsequent resignation of a director. However, the meeting's validity and the routine nature of the other resolutions temper the negativity.

Positives

• A quorum was successfully reached at the Annual Meeting, ensuring its validity despite technical difficulties.
• Stockholders ratified the appointment of Crowe LLP as the independent registered public accounting firm for 2025, indicating good governance.
• The resignation of Gary M. Winer from the Board was explicitly stated not to be due to any disagreement with the Company's operations, policies, or practices.

Negatives

• The company's service provider, Broadridge Financial Solutions, Inc., experienced technical difficulties during the virtual Annual Meeting, which may have prevented some stockholders from participating.
• Gary M. Winer was not re-elected as a Class I director, receiving significantly more 'Withheld' votes (410,361) than 'For' votes (133,365).

Risks

• Technical difficulties during virtual meetings can hinder shareholder engagement and participation, potentially leading to dissatisfaction or perceived lack of transparency.
• A vacant board seat, while not legally required to be filled, could impact board diversity, expertise, or workload distribution.

Future Outlook

The company has made a full replay of the Annual Meeting available for one year and has provided an email address for stockholders to submit questions until July 31, 2025, to ensure all stockholders have access to information and discussions.

Management Comments

• "We would like to inform you that, after the conclusion of our Annual Stockholder Meeting, our provider, Broadridge Financial Solutions Inc., advised us that it had encountered technical difficulties during the live webcast of our Meeting on June 17, 2025. Unfortunately, their issue prevented some of you from logging in and participating as we had intended. Broadridge extends its apology for any inconvenience or frustration this may have caused to you and to us." (Paraphrased from Exhibit 99.1 letter)
• "We greatly appreciate your continued support and thank you for your engagement as valued members of our stockholder community." (Paraphrased from Exhibit 99.1 letter)

Industry Context

Annual stockholder meetings are standard practice across all publicly traded companies, including those in the biotechnology sector, for electing directors, ratifying auditors, and addressing shareholder concerns. Virtual meeting platforms have become common, but technical issues, as experienced by HCW Biologics, can occasionally disrupt these events, highlighting the importance of robust digital infrastructure for shareholder engagement.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Some stockholders may have been prevented from participating in the virtual Annual Meeting due to technical difficulties, potentially impacting their ability to engage directly. However, the company has provided a replay and a mechanism for submitting questions post-meeting.
• Board of Directors: The board will operate with one less member following Mr. Winer's resignation and the decision not to fill the vacant seat.

Next Steps

• The replay of the Annual Meeting will be available for one year at www.virtualshareholdermeeting.com/HCWB2025.
• Stockholders may submit questions that they otherwise might have submitted at the Annual Meeting to info@hcwbiologics.com through July 31, 2025.
• Questions that follow the Meeting guidelines will be answered in a publicly available format.

Key Dates

Keywords

SEC filing, 8-K, Annual Meeting of Stockholders, Board of Directors, Director resignation, Corporate governance, Shareholder vote, Independent auditor, Crowe LLP, Technical difficulties, Virtual meeting, HCW Biologics Inc.